Exact Mass: 668.5591

Exact Mass Matches: 668.5591

Found 23 metabolites which its exact mass value is equals to given mass value 668.5591, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

2-Octaprenyl-6-methoxyphenol

2-methoxy-6-(all-trans-octaprenyl)phenol

C47H72O2 (668.5532)


A 2-methoxy-6-(all-trans-polyprenyl)phenol in which the substituent at position 6 is an all-trans-octaprenyl moiety.

   

DG(19:0/18:1(12Z)-2OH(9,10)/0:0)

(2S)-2-{[(9S,10S,12Z)-9,10-dihydroxyoctadec-12-enoyl]oxy}-3-hydroxypropyl nonadecanoic acid

C40H76O7 (668.5591)


DG(19:0/18:1(12Z)-2OH(9,10)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(19:0/18:1(12Z)-2OH(9,10)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(18:1(12Z)-2OH(9,10)/19:0/0:0)

(2S)-1-{[(9R,10R,12Z)-9,10-dihydroxyoctadec-12-enoyl]oxy}-3-hydroxypropan-2-yl nonadecanoic acid

C40H76O7 (668.5591)


DG(18:1(12Z)-2OH(9,10)/19:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(18:1(12Z)-2OH(9,10)/19:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(19:0/0:0/18:1(12Z)-2OH(9,10))

(2R)-3-{[(9R,10R,12Z)-9,10-dihydroxyoctadec-12-enoyl]oxy}-2-hydroxypropyl nonadecanoic acid

C40H76O7 (668.5591)


DG(19:0/0:0/18:1(12Z)-2OH(9,10)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(18:1(12Z)-2OH(9,10)/0:0/19:0)

(2S)-3-{[(9R,10R,12Z)-9,10-dihydroxyoctadec-12-enoyl]oxy}-2-hydroxypropyl nonadecanoic acid

C40H76O7 (668.5591)


DG(18:1(12Z)-2OH(9,10)/0:0/19:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-19:0/18:1(12Z)-2OH(9,10)/0:0)

(2S)-1-Hydroxy-3-[(17-methyloctadecanoyl)oxy]propan-2-yl (9S,10S,12Z)-9,10-dihydroxyoctadec-12-enoic acid

C40H76O7 (668.5591)


DG(i-19:0/18:1(12Z)-2OH(9,10)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-19:0/18:1(12Z)-2OH(9,10)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(18:1(12Z)-2OH(9,10)/i-19:0/0:0)

(2S)-3-Hydroxy-2-[(17-methyloctadecanoyl)oxy]propyl (9R,10R,12Z)-9,10-dihydroxyoctadec-12-enoic acid

C40H76O7 (668.5591)


DG(18:1(12Z)-2OH(9,10)/i-19:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(18:1(12Z)-2OH(9,10)/i-19:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-19:0/0:0/18:1(12Z)-2OH(9,10))

(2R)-2-Hydroxy-3-[(17-methyloctadecanoyl)oxy]propyl (9R,10R,12Z)-9,10-dihydroxyoctadec-12-enoic acid

C40H76O7 (668.5591)


DG(i-19:0/0:0/18:1(12Z)-2OH(9,10)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(18:1(12Z)-2OH(9,10)/0:0/i-19:0)

(2S)-2-Hydroxy-3-[(17-methyloctadecanoyl)oxy]propyl (9R,10R,12Z)-9,10-dihydroxyoctadec-12-enoic acid

C40H76O7 (668.5591)


DG(18:1(12Z)-2OH(9,10)/0:0/i-19:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-19:0/18:1(12Z)-2OH(9,10)/0:0)

DG(i-19:0/18:1(12Z)-2OH(9,10)/0:0)

C40H76O7 (668.5591)


   

DG(18:1(12Z)-2OH(9,10)/i-19:0/0:0)

DG(18:1(12Z)-2OH(9,10)/i-19:0/0:0)

C40H76O7 (668.5591)


   

DG(i-19:0/0:0/18:1(12Z)-2OH(9,10))

DG(i-19:0/0:0/18:1(12Z)-2OH(9,10))

C40H76O7 (668.5591)


   

DG(18:1(12Z)-2OH(9,10)/0:0/i-19:0)

DG(18:1(12Z)-2OH(9,10)/0:0/i-19:0)

C40H76O7 (668.5591)


   

DG(19:0/18:1(12Z)-2OH(9,10)/0:0)

DG(19:0/18:1(12Z)-2OH(9,10)/0:0)

C40H76O7 (668.5591)


   

DG(18:1(12Z)-2OH(9,10)/19:0/0:0)

DG(18:1(12Z)-2OH(9,10)/19:0/0:0)

C40H76O7 (668.5591)


   

DG(19:0/0:0/18:1(12Z)-2OH(9,10))

DG(19:0/0:0/18:1(12Z)-2OH(9,10))

C40H76O7 (668.5591)


   

DG(18:1(12Z)-2OH(9,10)/0:0/19:0)

DG(18:1(12Z)-2OH(9,10)/0:0/19:0)

C40H76O7 (668.5591)


   

[17-[(E)-5,6-dimethylhept-3-en-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] (4E,7E,10E,13E,16E)-nonadeca-4,7,10,13,16-pentaenoate

[17-[(E)-5,6-dimethylhept-3-en-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] (4E,7E,10E,13E,16E)-nonadeca-4,7,10,13,16-pentaenoate

C47H72O2 (668.5532)


   

[17-[(E)-5-ethyl-6-methylhept-3-en-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] (7E,9Z,11Z,13E,15E)-octadeca-7,9,11,13,15-pentaenoate

[17-[(E)-5-ethyl-6-methylhept-3-en-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] (7E,9Z,11Z,13E,15E)-octadeca-7,9,11,13,15-pentaenoate

C47H72O2 (668.5532)


   

ZyE(20:5)

ZyE(20:5)

C47H72O2 (668.5532)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

Octaprenylmethoxyphenol

Octaprenylmethoxyphenol

C47H72O2 (668.5532)


   

(6e)-3,7,11,15,19,23,27,31-octamethyldotriaconta-1,6,30-triene-3,10,11,15,19,23,27-heptol

(6e)-3,7,11,15,19,23,27,31-octamethyldotriaconta-1,6,30-triene-3,10,11,15,19,23,27-heptol

C40H76O7 (668.5591)